Profile
Genvira Biosciences is a preclinical oncology company developing viral vector-based therapies for cancers with high unmet need. Its lead program, GVB -2030, is being developed for bladder cancer and is designed to deliver an immune-activating payload directly into the tumor to help generate a more durable anti-tumor response in a disease where recurrence remains a major challenge. The company expects GVB-2030 to enter first-in-human studies in 2026.
Beyond its lead program, Genvira is building a broader pipeline through a proprietary viral vector engineering platform focused on improving genetic stability, payload design, immune activity, and manufacturability. Headquartered in Ottawa, Ontario, Genvira was spun out of the Ottawa Hospital Research Institute and operates from a biosafety-certified facility that supports its translational research and development activities. Genvira’s broader mission is to establish its Ottawa headquarters as a global center of excellence in viral vector engineering, translational research, and drug development. The company aims to advance its programs toward clinical proof-of-concept while creating long-term strategic value for Canada through innovation, skilled job creation, partnerships, and future commercialization opportunities.
Website
genvira.comContact
-
Jiahu Wang, Chief Executive Officer and FounderTel: +1 613-695-4718Email: jiahu.wang@genvira.com
-
-
-
-
-
Event details
Event contact
Participants
-
Founded in 2002, Amptek Technologies has been providing turnkey engineering design services since its inception.… -
BioBox builds the infrastructure that turns scientific judgment and reasoning into reproducible, scalable AI… -
The Center for Research on Environmental Microbiology (CREM Co Labs) is an Ontario-based research… -
The Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest, is a unique… -
Genvira Biosciences is a preclinical oncology company developing viral vector-based therapies for cancers with…
-
GRTHealth provides modular remote monitoring solutions to maximize the ability of seniors to live… -
i-RNA Corporation is a Canadian preclinical biotech developing small interfering… -
PurMinds NeuroPharma is a Canadian life-science company supporting the commercialization of point-of-care testing… -
QurCan Therapeutics is advancing the next wave of genetic medicines for CNS… -
RAN BioLinks Canada Ltd is a Canadian technology company headquartered in Toronto, that builds software for… -
Singularity Pharma is a drug discovery company developing novel drugs to treat CNS disorders with… -
Sussex Research Laboratories Inc. (Ottawa, Canada) is a globally recognized specialist in empowering therapeutic… -
Transpharmation is a company specializing in translational pharmacology that collaborates with pharmaceutical…